Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?

被引:10
作者
Stracciari, Andrea [1 ,2 ]
Bottini, Gabriella [3 ,4 ]
Guarino, Maria [5 ]
Magni, Eugenio [6 ]
Pantoni, Leonardo [7 ]
机构
[1] Univ Bologna, Bologna, Italy
[2] Italian Neurol Soc, Chair Cognit & Behav Neurol Study Grp, Bologna, Italy
[3] Univ Pavia, Brain & Behav Sci Dept, Neurosci & Soc Lab, Pavia, Italy
[4] Osped Niguarda Ca Granda, Cognit Neuropsychol Ctr, Milan, Italy
[5] S Orsola Malpighi Univ Hosp, Neurol Unit, IRCCS Ist Sci Neurol Bologna, Bologna, Italy
[6] Poliambulanza Fdn, Dept Neurosci, Brescia, Italy
[7] Univ Milan, Luigi Sacco Dept Biomed & Clin Sci, Stroke & Dementia Lab, Milan, Italy
关键词
COVID-19; Neurological complications; Cognitive disorders; Behavioral manifestations; Encephalopathy; RESPIRATORY-DISTRESS-SYNDROME; CORONAVIRUS DISEASE 2019; T-CELL THERAPY; COVID-19; ENCEPHALOPATHY; COMPLICATIONS; IMPAIRMENT;
D O I
10.1007/s10072-021-05231-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Patients with COVID-19 are increasingly reported to suffer from a wide range of neurological complications, affecting both the central and peripheral nervous system. Among central manifestations, cognitive and behavioral symptoms are to date not exhaustively detailed. Furthermore, it is not clear whether these represent a combination of non-specific complications of a severe systemic disease, not differing from those usually seen in patients suffering from heterogenous pathological conditions affecting the central nervous system, or instead, they are a peculiar expression of COVID-19 neurotropism; in other words, if the infection has a coincidental or causal role in such patients. We examined both hypotheses, reporting opposite points of view, with the aim to stimulate discussion and raise awareness of the topic.
引用
收藏
页码:2273 / 2281
页数:9
相关论文
共 77 条
[71]  
Waghray A., 2020, INTEGRATED ANAL SING, DOI [DOI 10.1101/2020.04.19.049254, 10.1101/2020.04.19.049254v2, 10.1101/2020.04.19.049254]
[72]   Neurological Manifestations of COVID-19: A systematic review and current update [J].
Whittaker, Abigail ;
Anson, Matthew ;
Harky, Amer .
ACTA NEUROLOGICA SCANDINAVICA, 2020, 142 (01) :14-22
[73]   The cerebral effects of ascent to high altitudes [J].
Wilson, Mark H. ;
Newman, Stanton ;
Imray, Chris H. .
LANCET NEUROLOGY, 2009, 8 (02) :175-191
[74]   Encephalopathy in patients with COVID-19: "Causality or coincidence?" [J].
Zayet, Souheil ;
Ben Abdallah, Yousri ;
Royer, Pierre-Yves ;
Toko, Lynda ;
Gendrin, Vincent ;
Klopfenstein, Timothee .
JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02)
[75]   Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality [J].
Zhang, Chi ;
Wu, Zhao ;
Li, Jia-Wen ;
Zhao, Hong ;
Wang, Gui-Qiang .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (05)
[76]   Extrapulmonary complications of COVID-19: A multisystem disease? [J].
Zheng, Kenneth, I ;
Feng, Gong ;
Liu, Wen-Yue ;
Targher, Giovanni ;
Byrne, Christopher D. ;
Zheng, Ming-Hua .
JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) :323-335
[77]   The landscape of cognitive function in recovered COVID-19 patients [J].
Zhou, Hetong ;
Lu, Shaojia ;
Chen, Jingkai ;
Wei, Ning ;
Wang, Dandan ;
Lyu, Hailong ;
Shi, Chuan ;
Hu, Shaohua .
JOURNAL OF PSYCHIATRIC RESEARCH, 2020, 129 :98-102